Regeneron Pharmaceuticals

Regeneron Invests $1.8 Billion in Tarrytown

US biotech Regeneron is planning to invest roughly $1.8 billion over six years to expand its research, preclinical manufacturing and support facilities at its Westchester County campus in Tarrytown, New York.

Bayer and Regeneron Explore Combination Eye Treatment

Regeneron and Sanofi to Appeal Patent Decision

Amgen Gets Nod for New Cholesterol Drug

Lucentis and Avastin Said to Have Similar Side Effects

Cholesterol Drug Halves Heart Attack and Stroke in Early Test

Bayer and Regeneron Widen Wet AMD Partnership

Bayer’s Eylea AMD Drug Hits Cost Evaluation Hurdle

Sanofi Interested in Buying Back L'Oreal's $12 Billion Stake

Biotech Firms Evolve from Targets to Acquirers

Fast Climbing Biotech Regeneron Still Has Room to Grow

Regeneron Says Sanofi to Boost Stake in its Shares

Amgen Biosimilar Push Takes Aim at Blockbusters

U.S. Health Advisers Back Two New Eye Treatments

Surge in Biotech Deals to Unlock Big Investor Profits